Dr S AZHAGU MADHAVAN

Author Details

1. S. azhagu madhavan

Author Statistics

Views : 631

Downloads : 145


Article Statistics

0
This article cited by 0

Search By Keyword

Keywords: lcsc
chemoresistant
tumor recurrence
hepatocellular carcinoma

Article File

PDF

Understanding the mechanism of drug-resistant and tumor recurrence in liver cancer

Author : S. azhagu madhavan

Keyword : Keywords: lcsc, chemoresistant, tumor recurrence, hepatocellular carcinoma

Subject : Pharmacy

Article Type : Original article (research)

Article QR Code

Understanding the mechanism of drug-resistant and  tumor recurrence in liver cancer QR Code

Article File : Full Text PDF

Abstract : Chemo-resistant and tumor recurrence are the major hurdle to overcome the cancer patients. Especially in hepatocellular carcinoma (HCC) is notoriously refractory to chemotherapy because of its tendency to develop multi-drug resistance (MDR), through various mechanisms. Aim: The current research is focussed on understanding the mechanism involved in chemo-resistant and tumor recurrence in liver cancer. Methods: Human hepatocellular carcinoma cell line (Huh7) was used entire study. Huh7 cells were cultured with known chemotherapeutic drugs such as 5-FU, Paclitaxel and Cisplatin-based on their Cmax concentration, and then these drug-treated cells were examined for chemoresistant and tumor recurrence properties through flow cytometry analysis, spheroid formation assay, and morphological analysis. Results: In morphological analysis confirm these all the chemo drugs were shown more cytotoxic effete than control, even though there were few viable cells noticed in cisplatin treatment. In flow cytometry analysis cisplatin pre-treated cells were well expressed LCSC marker such as CD133 and stem cell transduction factors like Oct-4 & Nanog than control. In addition to this, all the CD133 expressed cells also expressed to EpCAM. In spheroid formation assay, cisplatin pre-treated cells shown well-defined spheroid than control. Conclusion: LCSC plays a major role in chemoresistant and tumor recurrence through PI3K/Akt/mTOR, wnt-β catenin signaling, NF-kB signaling. So, targeting LCSC through EpCAM targeted therapy along with chemotherapy might be the better option for enhanced prognosis. .

Article by : Dr S AZHAGU MADHAVAN

Article add date : 2021-01-07


How to cite : S. azhagu madhavan. (2021-January-07). Understanding the mechanism of drug-resistant and tumor recurrence in liver cancer. retrieved from https://www.openacessjournal.com/abstract/534